黑色素瘤发病率的性别特异性评估
该横断面分析基于美国(白人)、加拿大、澳大利亚、新西兰、英国、瑞典、挪威和丹麦的癌症登记数据,评估了1982年至2015年男女性别及解剖部位特异性黑色素瘤发病率的趋势。结果显示,男性总体发病率在美国(白人)、加拿大、澳大利亚和新西兰高于女性,但在丹麦、英国、挪威和瑞典无此差异;男性在头颈部和躯干部发病率较高,而女性下肢发病率较高;男性与女性发病率比值随年龄呈对数线性增加。
要点
- 男性黑色素瘤总体发病率在部分国家高于女性,但存在人群差异。
- 男性头颈部和躯干部黑色素瘤发病率高于女性,女性下肢发病率较高。
- 男性与女性发病率比值随年龄增长而增加,年轻女性发病率较高,老年男性较高。
核心结论
- 在以白皙皮肤为主的人群中,黑色素瘤发病率在男女之间按年龄和解剖部位呈现系统且一致的差异。
主要发现
- 总黑色素瘤发病率在美国(限于白人)、加拿大、澳大利亚和新西兰男性高于女性,但在丹麦、英国、挪威和瑞典无此差异。
- 在所有人群中,男性头颈部和躯干黑色素瘤发病率高于女性(男性与女性IRR >1),但下肢黑色素瘤发病率较低(男性与女性IRR约为0.5)。
- 男性与女性IRR随年龄呈对数线性增加,所有人群中45岁以下女性黑色素瘤过多(如20-24岁年龄组IRR在丹麦为0.3,在澳大利亚为0.7),69岁以上男性黑色素瘤过多(如70-74岁年龄组IRR在丹麦为1.1,美国白种人群为2.1)。
- 男性黑色素瘤发病率超过女性的年龄因人群而异,澳大利亚最早(45-49岁),丹麦最晚(65-69岁)。
临床怎么用
- 临床应关注黑色素瘤发病率的性别和部位差异,针对不同年龄和性别进行针对性筛查。
局限性
- 研究为横断面分析,无法确定因果关系;美国数据仅限于白人,可能影响普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Men and women develop melanoma at different rates on different body sites, with variation across countries, but explanations for these disparities remain elusive. OBJECTIVE: To test whether observed differences in melanoma incidence between men and women vary by population, age, or anatomic site. DESIGN: Cross-sectional analysis of sex- and site-specific temporal trends in melanoma incidence over 3 decades was conducted for men and women diagnosed with invasive melanoma in the US (limited to white race), Canada, Australia, New Zealand, the UK, Sweden, Norway, and Denmark. Using cancer registry data, male to female incidence rate ratios (IRRs) were calculated overall and by anatomic site, and Joinpoint regression models were used to estimate the annual percentage rate changes in sex- and site-specific incidence in each population. Incidence rates were standardized to the US 2000 population. Data on the incidence between January 1, 1982, and December 31, 2015, were obtained; analysis was conducted from March 1 to October 15, 2019. MAIN OUTCOMES AND MEASURES: Male to female IRRs and annual percentage change in rates. RESULTS: Total melanoma incidence was higher in men than women in US individuals (limited to white race), Canada, Australia, and New Zealand, but not in Denmark, the UK, Norway, and Sweden. In all populations, men had higher rates of melanoma of the head and neck and trunk than women (male to female IRR >1), but lower melanoma rates on the lower limbs (ie, male to female IRR approximately 0.5). The male to female IRR increased log linearly with age, with excess melanomas in women younger than 45 years in all populations (eg, IRR for 20-24 y age group, 0.3 in Denmark and 0.7 in Australia), and excess melanomas in men older than 69 years (eg, IRR for 70-74 y age group, 1.1 in Denmark and 2.1 in the US white population). The age at which the melanoma incidence in men exceeded the melanoma incidence in women differed by population, being achieved the earliest in Australia (45-49 years) and latest in Denmark (65-69 years). CONCLUSIONS AND RELEVANCE: In predominantly fair-skinned populations, melanoma incidence appears to differ systematically and consistently between men and women by age and anatomic site.
引用
- Olsen CM, Thompson JF, Pandeya N, et al. Evaluation of Sex-Specific Incidence of Melanoma. JAMA Dermatol. 2020. PMID: 32211827. doi:10.1001/jamadermatol.2020.0470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。